EyeGene Market Cap

EyeGene has a market cap or net worth of 63.98 billion as of May 15, 2026. Its market cap has decreased by -37.46% in one year.

Market Cap

63.98B

Enterprise Value

18.08B

Revenue

3.57B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,449.00

Market Cap Chart

Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 63.98B, a decrease of -51.16%. That is a compound annual growth rate of -6.60%.

Market Cap History

Date	Market Cap	% Change
May 14, 2026	63.98B	-14.89%
Dec 30, 2025	75.18B	8.64%
Dec 30, 2024	69.20B	-24.46%
Dec 28, 2023	91.61B	-15.21%
Dec 29, 2022	108.04B	-73.58%
Dec 30, 2021	408.92B	175.32%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PanGen Biotech	82.45B
Naturalendo Tech	75.62B
Shaperon	73.02B
IMGT Co.,Ltd.	69.33B
Ark Solutions	68.91B
Quratis	66.19B
Psomagen	64.54B
Progen	63.65B

Market Cap Rankings